反脂抗体和血栓形成的抗体
1Department of Medicine and Therapeutics, Foresterhill, Aberdeen, UK. m.greaves@abdn.ac.uk
Lancet (London, England)
|April 28, 1999
概括
抗脂抗体表明血液凝块和流产的风险. 识别抗脂综合征对于管理复发性血栓形成和指导抗血栓治疗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
背景情况:
- 抗脂抗体与血栓形成,重复流产和血栓塞缩症有关.
- 这些抗体作为抗脂综合征 (APS) 的关键实验室标记物.
研究的目的:
- 为了突出鉴定APS由于复发性血栓形成风险的临床重要性.
- 为了强调在许多APS病例中需要抗血栓治疗.
主要方法:
- 对APS的临床关联和实验室标记的审查.
- 对诊断挑战和治疗局限性的分析.
主要成果:
- 鉴定APS对于管理复发性血栓事件至关重要.
- 对于APS患者来说,通常需要有效的抗血栓治疗.
结论:
- 由于不同的临床特征,APS的诊断和管理是复杂的.
- 目前抗体检测的局限性以及缺乏基于证据的指导方针,阻碍了最佳的患者护理.
相关概念视频
Inflammation
Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...


